 Tumor-targeted chemotherapy lipid contrast medium macromolecular anticancer drug SMANCS renal cell carcinoma Twenty-five patients renal cell carcinoma lipophilic macromolecular drug poly stylene-co-maleic acid neocarzinostatin SMANCS lipid contrast medium Lipiodol drug renal artery feeding artery patients common hepatic artery patient metastases liver radical nephrectomy procedure selective arterial administration mg/mL SMANCS/Lipiodol simple weeks Total dose SMANCS patient mg SMANCS Lipiodol tumor tissue neovasculature extracapillary space long time CT pattern oil contrast medium tumor high-density area periphery tumor central necrosis hyperviscosity Lipiodol Lipiodol HV lipid contrast medium tumor Lipiodol pronounced anticancer effect SMANCS/Lipiodol HV SMANCS/Lipiodol Severe side effects myelosuppression unendurable pain paralytic ileus chemotherapy great significance advanced renal cell carcinoma